September is blood cancer awareness month and this year we are asking you to get involved. The rates of blood cancer diagnosis and mortality are increasing year on year and Snowdome needs your help to find better treatments for this indiscriminate disease. We are asking you to kiss a vice goodbye for the month of … Continued
The Leukemia & Lymphoma Society conducted a large trial to examine if the mRNA (Pfizer and Moderna) COVID-19 vaccines provided antibody protection against the SARS-CoV-2 virus in people with a blood cancer. It was just published in Cancer Cell. Two weeks after their second COVID-19 vaccine 1400 blood cancer patients had their antibody levels tested … Continued
Dr Mary Ann Anderson was awarded the Gandel Philanthropy – Snowdome Foundation Innovation Fellowship in 2016. Since that time, she has become recognised as a world-leading expert through her pioneering work uncovering invaluable information about the novel treatment, venetoclax in the treatment of lymphoma and chronic lymphocytic leukaemia. Funded by Gandel Philanthropy, through the Snowdome … Continued
Karina Stell endured three cancer diagnoses during her life, including both Hodgkin and non-Hodgkin Lymphoma. Karina wanted to share her experience with others, to help them on their own journey. It was Karina’s wish to fund blood cancer research. Karina wanted to help others find a treatment that worked. Part proceeds from the sale of … Continued
Introducing “The Bloody Good Red” wine fundraising project. This exciting project is a collaboration between the Snowdome Foundation, Calneggia Family Vineyards and Naked Wines Australia. Mike and Sally Calneggia, own Calneggia Family Vineyards in Margaret River, Western Australia. Sadly, they lost Mike’s father Jim to Multiple Myeloma and since that time the Calneggia Family has … Continued
Fifteen years ago, the father of fashion designer, Lisa Gorman was diagnosed with two forms of blood cancer – lymphoma and leukaemia. As Lisa’s father began treatment, it became evident that more funding was required for research to uncover new treatments and better ways to manage the condition. It was during this period that Lisa … Continued
Dr Belinda Guo is the recipient of the 2019-2021 Gunn Family National Career Development Fellowship for Women in Haematology. For the past three years Belinda has researched novel blood biomarkers for predicting bone marrow failure in myeloproliferative neoplasms. During that time she has made great advances in identifying markers to monitor disease progression. Myeloproliferative neoplasm … Continued
Dinner of Hope 2021 Clinical trials are a pathway to hope for blood cancer patients. Trials provide access to next generation treatments when everything else has failed your body. However, clinical trials require human infrastructure that doesn’t exist in the ‘normal’ hospital setting. A clinical research fellow is required to identify trials that meet individual … Continued
Research into the treatment, known as chimeric antigen receptor T-cell therapy (CAR T-cell), shows it is more effective than current cancer treatments, but effectiveness does not imply value as far as health budgets are concerned. Australian and US blood cancer specialists reviewed the current measures of cost effectiveness and identified multiple strategies that could be … Continued